DISHMAN CARBOGEN AMCIS Fact Sheet, DISHMAN CARBOGEN AMCIS Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN CARBOGEN AMCIS Fact Sheet   (DCAL)



Here is the latest financial fact sheet of DISHMAN CARBOGEN AMCIS. For more details, see the DISHMAN CARBOGEN AMCIS quarterly results and DISHMAN CARBOGEN AMCIS share price and chart. For a sector overview, read our pharmaceuticals sector report.

DISHMAN CARBOGEN AMCIS Price History

Price Rs 116.4
Mkt Cap Rs m 18,250
Vol '000 46.5
P/E X 101.6
P/CF X 12.8
EPS (TTM) Rs 1.1
1 Day % -0.9
No. of shares m 156.78
1 Week % 2.0
1 Month % -8.1
1 Year % -45.6
52 week H/L Rs 259.5/97.6
As on Jul 4, 2022 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

DISHMAN CARBOGEN AMCIS Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
DISHMAN CARBOGEN AMCIS EQUITY SHARE DATA
High RsNA397387258217 
Low RsNA2751804653 
Sales per share (Unadj.) Rs0105.0127.6130.3122.0 
Earnings per share (Unadj.) Rs09.613.010.1-10.5 
Diluted earnings per shareRs09.913.410.1-10.5 
Cash flow per share (Unadj.) Rs022.727.928.19.1 
Dividends per share (Unadj.) Rs000.2000 
Adj. dividends per shareRs0.000.000.210.000.00 
Avg Dividend yield %000.100 
Book value per share (Unadj.) Rs0316.5333.3364.3363.5 
Adj. book value per shareRs0325.8343.1364.5363.5 
Shares outstanding (eoy) m0161.39161.39156.86156.78 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x03.22.21.21.1 
Avg P/E ratio x035.121.715.1-12.8 
P/CF ratio (eoy) x014.810.15.414.8 
Price / Book Value ratio x01.10.90.40.4 
Dividend payout %001.500 
Avg Mkt Cap Rs m054,19245,74323,89021,142 
No. of employees `000NANANANANA 
Total wages/salary Rs m5,9606,2547,1467,6238,729 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
DISHMAN CARBOGEN AMCIS INCOME DATA
Net Sales Rs m17,13716,94820,58620,43619,120 
Other income Rs m261530538445385 
Total revenues Rs m17,39817,47821,12420,88119,505 
Gross profit Rs m4,5344,3805,5194,9762,521 
Depreciation Rs m2,1352,1142,4042,8293,079 
Interest Rs m490488566620476 
Profit before tax Rs m2,1702,3083,0881,972-650 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m7077629853871,001 
Profit after tax Rs m1,4631,5462,1031,585-1,651 
Gross profit margin %26.525.826.824.313.2 
Effective tax rate %32.633.031.919.6-153.9 
Net profit margin %8.59.110.27.8-8.6 
DISHMAN CARBOGEN AMCIS BALANCE SHEET DATA
Current assets Rs m13,33115,46215,53617,79016,626 
Current liabilities Rs m9,93711,77711,98315,69012,488 
Net working cap to sales %19.821.717.310.321.6 
Current ratio x1.31.31.31.11.3 
Inventory Days Days5610992110118 
Debtors Days Days6108107 
Net fixed assets Rs m52,41356,22957,67064,14466,517 
Share capital Rs m0323323314314 
"Free" reserves Rs m4050,75153,46856,83756,675 
Net worth Rs m4051,07353,79157,15156,988 
Long term debt Rs m4,6015,2503,6242,4135,039 
Total assets Rs m65,74371,69073,20581,93483,144 
Interest coverage x5.45.76.54.2-0.4 
Debt to equity ratio x115.60.10.100.1 
Sales to assets ratio x0.30.20.30.20.2 
Return on assets %3.02.83.62.7-1.4 
Return on equity %3,676.43.03.92.8-2.9 
Return on capital %57.35.06.44.4-0.3 
Exports to sales %00000 
Imports to sales %00000 
Exports (fob) Rs m00000 
Imports (cif) Rs m00000 
Fx inflow Rs m4,0534,5525,1285,0551,554 
Fx outflow Rs m116126145141210 
Net fx Rs m3,9384,4264,9834,9141,343 
DISHMAN CARBOGEN AMCIS CASH FLOW
From Operations Rs m 3,027 2,264 2,820 5,851 5,134 
From Investments Rs m -1,424 -2,972 -1,690 -4,417 -3,808 
From Financial Activity Rs m -1,371 776 -1,022 -978 -110 
Net Cashflow Rs m 586 69 108 456 1,216 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 59.3%
Institution 12.4%
Non-Institution 28.3%
Total 100.0%
Free Float 40.7%
Pledged promoter holdings 0.0%
Shareholding as on Mar 2022
 

Company Information

Regd Off Dishman Corporate House, Lscon-bopal Road, Ambli, Ahmedabad - 380058
E-mail dishman@dishmangroup.com Web www.dishmangroup.com
Tel 02717 420102/124 Fax
Sector PHARMACEUTICALS Group Dishman Pharma
Tr Agent Link Intime India Pvt Ltd., C 101 247 Park, LBS Marg, Vikhroli (West)
CHM: Janmejay R Vyas COMP SEC: Shrima Dave YEAR OF INC: 2007 BSE CODE: 540701 FV (Rs): 2 DIV YIELD (%): -

Read: DISHMAN CARBOGEN AMCIS 2020-21 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    LUPIN    

Compare DISHMAN CARBOGEN AMCIS With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    LUPIN    


Yellow Ad

Advertisement

Last Day to Access 'One Stock Crorepati' Opportunity

As you know, recently we went LIVE with our One Stock Crorepati MEGA Summit...

Around 10,000 readers like you had registered to attend this summit.

At the summit, they learned Richa Agarwal's secret blueprint of identifying potential 'crorepati' stocks.

Plus, they also discovered the details of one stock with crorepati potential...

If you missed this summit for some reason, then you can still get all the details by watching this special replay of the summit.

Learn more



Today's Market

Sensex Ends 327 Points Higher as FMCG Stocks Rally; HUL, Britannia & ITC Top Gainers(Closing)

After opening the day on a choppy note, Indian share markets rallied as the session progressed and ended higher.

Views on news

Pharma Company to Issue Bonus Shares this Week. Are you Eligible? (Views On News)

Jul 4, 2022

The company has also announced a final dividend of Rs 23 per equity share recently.

5 Takeaways from Sun Pharma's Q4 Results (Views On News)

May 30, 2022

It came as a surprise to everyone when Sun Pharma reported a consolidated net loss in Q4 instead of a profit.

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

More Views on News

Most Popular

The One Smallcap Stock I'll Recommend Now (Profit Hunter)

Jun 21, 2022

This aspect of investing has a very high weightage on your overall returns, but often gets ignored when winning stories are written.

5 Consistent Compounding Stocks Available at Discount. Time to Buy? (Views On News)

Jun 22, 2022

The good side of a market correction? Investors get consistent compounding stocks at a discount.

Auto Stocks are in the Fast Lane. Is it Time to Buy? (Profit Hunter)

Jun 23, 2022

The auto index is outperforming the Nifty by a mile. Have auto stocks finally bottomed out?

5 Indian Companies where Mutual Fund Holdings are Consistently Increasing (Views On News)

Jul 1, 2022

Mutual funds are buying shares at a time when FIIs are consistently selling. Here are 5 stocks where MF holdings has increased for the past 4 quarters.

Why Crude Oil Price is Falling (Views On News)

Jun 25, 2022

Global markets have become volatile, sending chills through the crude oil market.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK DISHMAN CARBOGEN AMCIS

  • Track your investment in DISHMAN CARBOGEN AMCIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DISHMAN CARBOGEN AMCIS

DISHMAN CARBOGEN AMCIS - SYNCOM FORMULATIONS COMPARISON

COMPARE DISHMAN CARBOGEN AMCIS WITH

MARKET STATS